%
% GALE automatic stratified fold generation for CV
%
% Generated at        : Wed Feb 21 23:57:18 CET 2001
% Random seed         : 69
% File name           : GALE.hepatitis.cv.seed.69.fold.000008.test.arff
% Number of instances : 16
%

@RELATION hepatitis

@ATTRIBUTE	AGE	INTEGER [10,80]
@ATTRIBUTE	SEX	{male,female}
@ATTRIBUTE	STEROID	{no,yes}
@ATTRIBUTE	ANTIVIRALS	{no,yes}
@ATTRIBUTE	FATIGUE	{no,yes}
@ATTRIBUTE	MALAISE	{no,yes}
@ATTRIBUTE	ANOREXIA	{no,yes}
@ATTRIBUTE	LIVER_BIG	{no,yes}
@ATTRIBUTE	LIVER_FIRM	{no,yes}
@ATTRIBUTE	SPLEEN_PALPABLE	{no,yes}
@ATTRIBUTE	SPIDERS	{no,yes}
@ATTRIBUTE	ASCITES	{no,yes}
@ATTRIBUTE	VARICES	{no,yes}
@ATTRIBUTE	BILIRUBIN	REAL
@ATTRIBUTE	ALK_PHOSPHATE	INTEGER [33,250]
@ATTRIBUTE	SGOT	INTEGER [13,500]
@ATTRIBUTE	ALBUMIN	REAL
@ATTRIBUTE	PROTIME	INTEGER [10,90]
@ATTRIBUTE	HISTOLOGY	{no,yes}
@ATTRIBUTE	Class	{DIE,LIVE}

@DATA
26,male,no,no,no,no,no,yes,yes,no,no,no,no,0.5,135,29,3.8,60,no,LIVE
52,female,no,yes,no,no,no,yes,no,no,no,no,no,0.7,75,55,4.0,21,no,LIVE
44,female,no,no,yes,yes,no,yes,no,yes,no,no,yes,0.9,135,55,?,41,yes,DIE
37,female,no,no,yes,yes,yes,yes,no,no,no,no,no,0.8,92,59,?,?,no,LIVE
43,female,yes,no,yes,no,no,yes,no,yes,yes,yes,no,1.2,100,19,3.1,42,yes,DIE
34,female,yes,no,no,no,no,yes,no,no,no,no,no,?,?,86,?,?,no,LIVE
37,female,yes,no,no,no,no,yes,no,no,no,no,no,0.7,26,58,4.5,100,no,LIVE
51,female,yes,no,yes,yes,yes,?,?,?,?,?,?,0.9,76,271,4.4,?,no,LIVE
41,female,yes,yes,yes,no,no,yes,yes,no,no,no,no,0.9,81,60,3.9,52,no,LIVE
53,male,no,no,yes,no,no,yes,no,yes,yes,no,yes,1.5,81,19,4.1,48,yes,LIVE
70,female,no,no,yes,yes,yes,?,?,?,?,?,?,1.7,109,528,2.8,35,yes,DIE
23,female,yes,no,yes,yes,yes,yes,no,yes,no,no,no,1.3,194,150,4.1,90,no,LIVE
54,female,no,yes,no,no,no,no,yes,no,no,no,no,1.0,155,225,3.6,67,yes,LIVE
32,female,no,yes,yes,yes,no,yes,no,no,no,no,no,1.0,55,45,4.1,56,no,LIVE
28,female,yes,no,no,no,no,yes,no,no,no,no,no,0.7,85,31,4.9,?,no,LIVE
25,female,yes,no,yes,no,no,no,yes,yes,yes,yes,yes,1.3,181,181,4.5,57,yes,LIVE
